4-((3Z)-3-(2-dimethylaminoethyl)oxyimino-3-(2-fluorophenyl)propen-1-yl)phenol hemifumarate,
SR 46349,
SR 46349B,
SR-46349,
SR-46349B,
Eplivanserin fumarate,
SR-46349B,
130580-02-8,
Eplivanserin hemifumarate,
UNII-BT8UYC46KA,
BT8UYC46KA,
SR 46349,
SR 46349B,
4-((3Z)-3-(2-Dimethylaminoethyl)oxyimino-3-(2-fluorophenyl)propen-1-yl)phenol hemifumarate,
2-Propen-1-one, 1-(2-fluorophenyl)-3-(4-hydroxyphenyl)-, O-(2-(dimethylamino)ethyl)oxime, (Z,E)-, (E)-2-butenedioate (2:1) (salt),
SR-46349 hemifumarate,
Eplivanserin hemifumarate salt,
Eplivanserin fumarate [USAN],
SCHEMBL678915,
SR-46349 hemifumarate salt,
CHEMBL2103845,
AKOS025142034,
LS-184149,
SR-46349 hemifumarate salt, >=98% (HPLC),
(1Z,2E)-1-(2-Fluorophenyl)-3-(4-hydroxyphenyl)-2-propen-1-one O-[2-(dimethylamino)ethyl]oxime hemifumarate,
4-((3Z)-3-(2-Dimethylaminoethyl)oxyimino-3-(2-fluorophenyl)propen-1-yl)phenol hemifumarate salt,
SR-46349,
C076033,
(E)-1-(2-FLUORO-PHENYL)-3-(4-HYDROXY-PHENYL)-PROPENONE O-(2-DIMETHYLAMINO-ETHYL)-OXIME HEMI-FUMARATE,